Celldex Therapeutics, Inc. (CLDX)
27.51
-0.43
(-1.54%)
USD |
NASDAQ |
Dec 12, 16:00
27.52
+0.02
(+0.05%)
After-Hours: 20:00
Celldex Therapeutics EPS Diluted (Quarterly): -1.009 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Atossa Therapeutics, Inc. | -0.0673 |
| Abeona Therapeutics, Inc. | -0.0952 |
| Phibro Animal Health Corp. | 0.649 |
| Kiora Pharmaceuticals, Inc. | 0.0062 |
| Intellia Therapeutics, Inc. | -0.9196 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.04M |
| Total Expenses (Quarterly) | 67.04M |
| Enterprise Value | 1.253B |
| Earnings Yield | -12.29% |
| Normalized Earnings Yield | -12.29 |